Words of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Eur Urol. 2015 May;67(5):975. doi: 10.1016/j.eururo.2014.12.065.

Authors

Zachary S Buchwald¹, Jason A Efstathiou²

Affiliations

¹ Saint Louis University, Saint Louis, MO, USA.
² Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jefstathiou@partners.org.

PMID: 25845961
DOI: 10.1016/j.eururo.2014.12.065

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Female
Humans
Immunotherapy*
Male
Urinary Bladder Neoplasms / therapy*

Substances

Antibodies, Monoclonal